Interindividual variability of canalicular ATP-binding-cassette (ABC)–transporter expression in human liver
Top Cited Papers
Open Access
- 23 June 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 44 (1) , 62-74
- https://doi.org/10.1002/hep.21214
Abstract
Interindividual variability in hepatic canalicular transporter expression might predispose to the development of hepatic disorders such as acquired forms of intrahepatic cholestasis. We therefore investigated expression patterns of bile salt export pump (BSEP, ABCB11 ), multidrug resistance protein 3 (MDR3, ABCB4 ), multidrug resistance associated protein 2 (MRP2, ABCC2 ) and multidrug resistance protein 1 (MDR1, ABCB1) in healthy liver tissue of a white population. Protein expression levels were correlated with specific single nucleotide polymorphisms (SNPs) in the corresponding transporter genes. Hepatic protein expression levels from 110 individuals undergoing liver resection were assessed by Western blot analysis of liver plasma membranes enriched in canalicular marker enzymes. Each individual was genotyped for the following synonymous (s) and nonsynonymous (ns) SNPs: ABCB11: (ns:1457T>C and 2155A>G), ABCB4: (ns:3826A>G) and ABCC2 (ns:1286G>A,3600T>A and 4581G>A) and ABCB1 (ns:2677G>T/A and s:3435C>T). Transporter expression followed unimodal distribution. However, of all tested individuals 30% exhibited a high expression and 32% a low or very low expression phenotype for at least one of the four investigated transport proteins. Transporter expression levels did not correlate with age, sex, underlying liver disease, or presurgery medication. However, low BSEP expression was associated with the 1457C-allele in ABCB11 ( P = .167) and high MRP2 expression was significantly correlated with the 3600A and 4581A ABCC2 variants ( P = .006). In conclusion , the results demonstrate a considerable interindividual variability of canalicular transporter expression in normal liver. Furthermore, data suggest a polymorphic transporter expression pattern, which might constitute a risk factor for the development of acquired forms of cholestatic liver diseases. Supplementary material for this article can be found on the HEPATOLOGY website (http://interscience.wiley.com/jpages/0270-9139/suppmat/index.html)Keywords
This publication has 37 references indexed in Scilit:
- 306 Possible role of BSEP-mediated bile acid transport inhibition by progesterone metabolites in the aetiopathogenesis of intrahepatic cholestasis of pregnancyJournal of Hepatology, 2005
- Molecular Regulation of Hepatobiliary Transport SystemsJournal of Clinical Gastroenterology, 2005
- High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)Pharmacogenetics, 2004
- High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver diseaseThe Journal of Pathology, 2003
- Mammalian ABC Transporters in Health and DiseaseAnnual Review of Biochemistry, 2002
- Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseasesHepatology, 2001
- Molecular Alterations in Hepatocyte Transport Mechanisms in Acquired Cholestatic Liver DisordersSeminars in Liver Disease, 2000
- Isolation and characterization of canalicular and basolateral plasma membrane fractions from human liverBiochimica et Biophysica Acta (BBA) - Biomembranes, 1991
- Mechanism of Cholesterol Gallstones FormationSeminars in Liver Disease, 1983
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970